Medical Devices
Technology
Health

Meridian Bioscience

$17.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.41 (2.47%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell VIVO and other stocks, options, ETFs, and crypto commission-free!

About

Meridian Bioscience, Inc. engages in the development, manufacture, sale, and distribution of diagnostic test kits, antigens, reagents, and related products. It operates through the Diagnostics and Life Science segment. Read More The Diagnostics segment consists testing platforms and technologies such as Isothermal DNA Amplification, Rapid Immunoassay, Enzyme-linked Immunoassay, and Anodic Stripping Voltammetry. The Life Science segment distributes bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.

Employees
585
Headquarters
Cincinnati, Ohio
Founded
1976
Market Cap
704.89M
Price-Earnings Ratio
28.55
Dividend Yield
3.36
Average Volume
259.48K
High Today
$17.12
Low Today
$16.51
Open Price
$16.51
Volume
167.57K
52 Week High
$19.84
52 Week Low
$13.75

Collections

Medical Devices
Technology
Health
Biotechnology
Manufacturing
Medical
US
North America

News

Simply Wall StMar 18

Meridian Bioscience, Inc. (NASDAQ:VIVO): Is Growth Priced In?

Growth expectations for Meridian Bioscience, Inc. (NASDAQ:VIVO) are high, but many investors are starting to ask whether its last close at $16.5 can still be rationalized by the future potential. Let’s take a look at some key metrics to determine whether there’s any value here for current and potential future investors. See our latest analysis for Meridian Bioscience Has the VIVO train has slowed down? Is VIVO’s share price justified by its earnings growth? Investors in Meridian Bioscience have been pat...

9
TradingNewsNowMar 7

Present Trend: Meridian Bioscience (NASDAQ: VIVO)

Meridian Bioscience trades as part of the medical diagnostics and research industry and is part of the healthcare sector. The company CEO is Jack P. Kenny. Meridian Bioscience Inc is an integrated life science company. It is engaged in development, manufacture, sale and distribution of diagnostic test kits for certain gastrointestinal, viral, respiratory and parasitic infectious diseases. Previous Intraday Trading Performance: The VIVO stock showed a previous change of 0.37% with an open at 16.41 and a cl...

17
Yahoo FinanceMar 5

Did Meridian Bioscience, Inc. (NASDAQ:VIVO) Insiders Sell Shares?

It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So shareholders might well want to know whether insiders have been buying or selling shares in Meridian Bioscience, Inc. (NASDAQ:VIVO). Do Insider Transactions Matter? Scroll to continue with content Ad Most investors know that it is quite permissible for company leaders, such as directors of t...

17

Earnings

$0.14
$0.18
$0.21
$0.25
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Apr 25, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.